Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics, Inc. (APGE)
NASDAQ:APGE
RESEARCH TOOLSreports
Apogee Therapeutics, Inc. (APGE) Ownership - Who Owns Apogee Therapeutics, Inc.?
79 Followers
Apogee Therapeutics, Inc. (APGE) Ownership Overview
9.09% Insiders
14.51% Mutual Funds
12.12% Other Institutional Investors
64.28% Public Companies and Individual Investors
The ownership structure of Apogee Therapeutics, Inc. (APGE) stock is a mix of institutional, retail and individual investors. Approximately 26.63% of the company’s stock is owned by Institutional Investors, 9.09% is owned by Insiders and 64.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 17, 2023 | Fairmount Funds Management Llc Director | Bought | $49999992 |
| Jul 17, 2023 | Nimish P Shah Director | Bought | $29750000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $38557 | |
| Dec 31, 2023 | Bought | $9111289 | |
| Dec 31, 2023 | Bought | $9829571 | |
| Dec 31, 2023 | Sold | $37134048 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,941,176 | Institution | 6.85% | 159,735,269 | |
| 1,977,901 | Institution | 4.61% | 107,419,803 | |
| 1,827,901 | Institution | 4.26% | 99,273,303 | |
| 1,753,170 | Institution | 4.08% | 95,214,663 | |
| 1,685,123 | Institution | 3.93% | 91,519,030 | |
| 1,664,026 | Institution | 3.88% | 90,373,252 | |
| 1,329,064 | Institution | 3.10% | 72,181,466 | |
| 1,007,602 | Institution | 2.35% | 54,722,865 | |
| 749,156 | Institution | 1.75% | 40,686,662 | |
| 680,439 | Institution | 1.59% | 36,954,642 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,664,026 | Institution | 3.88% | 90,373,252 | |
| 1,007,602 | Institution | 2.35% | 54,722,865 | |
| 749,156 | Institution | 1.75% | 40,686,662 | |
| 680,439 | Institution | 1.59% | 36,954,642 | |
| 470,123 | Institution | 1.10% | 25,532,380 | |
| 378,956 | Institution | 0.88% | 20,581,100 | |
| 223,534 | Institution | 0.52% | 12,140,132 | |
| 218,712 | Institution | 0.51% | 11,878,249 | |
| 211,457 | Institution | 0.49% | 11,484,230 | |
| 92,081 | Institution | 0.21% | 5,000,919 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,176,138 | Institution | 2.74% | 78,154,370 | |
| 970,505 | Institution | 2.26% | 52,708,127 | |
| 522,260 | Institution | 1.22% | 28,301,269 | |
| 387,559 | Institution | 0.90% | 25,753,296 | |
| 257,693 | Institution | 0.60% | 13,995,307 | |
| 210,309 | Institution | 0.49% | 11,421,882 | |
| 154,460 | Institution | 0.36% | 10,263,867 | |
| 158,289 | Institution | 0.37% | 8,596,676 | |
| 122,435 | Institution | 0.29% | 6,634,753 | |
| 53,946 | Institution | 0.13% | 2,929,807 |
FAQ
Who Owns Apogee Therapeutics, Inc. (APGE)?
According to the latest TipRanks data, approximately 12.12% of the company's stock is held by institutional investors, 9.09% is held by insiders, and 64.28% is held by retail investors.
What percentage of Apogee Therapeutics, Inc. (APGE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.12% of Apogee Therapeutics, Inc. (APGE) stock is held by institutional investors.
What percentage of Apogee Therapeutics, Inc. (APGE) stock is held by retail investors?
According to the latest TipRanks data, approximately 64.28% of Apogee Therapeutics, Inc. (APGE) stock is held by retail investors.
Who owns the most shares of Apogee Therapeutics, Inc. (APGE)?
Peter Harwin owns the most shares of Apogee Therapeutics, Inc. (APGE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.